Chronic Glucocorticoid Exposure Potentiates Placental Chorionic Plate Artery Constriction: Implications for Aberrant Fetoplacental Vascular Resistance in Fetal Growth Restriction

Author:

Nugent J. L.1,Wareing M.1,Palin V.1,Sibley C. P.1,Baker P. N.2,Ray D. W.3,Farrow S. N.3,Jones R. L.1

Affiliation:

1. Maternal and Fetal Health Research Centre (J.L.N., M.W., V.P., C.P.S., R.L.J.)

2. Liggins Institute (P.N.B.), University of Auckland, 1142 Auckland, New Zealand

3. Endocrine Sciences Research Group (D.W.R., S.N.F.), Institute of Human Development, Manchester Academic Health Science Centre, University of Manchester, Manchester M13 9WL, United Kingdom

Abstract

Fetal growth restriction (FGR) is a serious pregnancy complication, resulting in significant perinatal morbidity and mortality. Increased vascular resistance in the fetoplacental circulation is a hallmark of FGR and is associated with enhanced vasoconstriction of the resistance arteries in the placenta, the chorionic plate arteries (CPAs). Although the cause is unknown, FGR is associated with excess exposure to glucocorticoids (GCs), key mediators of vascular resistance in the systemic circulation. We hypothesized that GCs alter CPA reactivity, thereby contributing to the altered blood flow dynamics seen in FGR. We aimed to examine the acute and chronic effects of GCs on CPA reactivity and the operational mechanisms. Glucocorticoid receptors were highly expressed by CPA. 11β-Hydroxysteroid isoenzyme type 2 was detected within the endothelium, whereas 11β-hydroxysteroid isoenzyme type 1 was absent. Acute GC treatment significantly attenuated U46619-induced constriction. This effect was reversed by cotreatment with mifepristone or an endothelial NOS inhibitor. In contrast, chronic GC treatment potentiated U46619 constriction in a dose-dependent manner, which was partially abolished by mifepristone cotreatment. Similar effects were observed using a novel nonsteroidal glucocorticoid receptor-specific agonist. Chronic treatment with GCs altered the expression of several vasoactive factors, including thromboxane and bradykinin receptors, prokineticin-1, cyclooxygenase-2, and endothelial NOS. In summary, acute and chronic GC treatment exerts contrasting effects on CPA vasoreactivity. These opposing effects are consistent with temporal actions in other vascular beds and reflect activation of distinct nongenomic and genomic pathways. Chronic exposure to elevated GCs may contribute to the raised vascular resistance observed in the fetoplacental circulation in FGR.

Publisher

The Endocrine Society

Subject

Endocrinology

Reference50 articles.

1. Fifth Annual Report of the Perinatal and Maternal Mortality Review Committee: Reporting Mortality 2009;Perinatal and Maternal Mortality Review Committee,2011

2. Stillbirth and fetal growth restriction;Bukowski;Clin Obstet Gynecol

3. Fetal programming and metabolic syndrome;Rinaudo;Annu Rev Physiol,2012

4. Developmental origins of adult disease;Langley-Evans;Med Princ Pract,2010

5. Umbilical artery blood flow characteristics in normal and growth–retarded fetuses;Erskine;Br J Obstet Gynaecol,1985

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3